Name: 글로벌 시장 동향
SKU: MD6745
Availability: InStock

보고서 요약(국문)

시장 개요
글로벌 조직 처리 시스템 시장은 2022년 3억 8,320만 달러에 달했으며, 2023년부터 2030년까지 연평균 5.4%의 성장률을 보이며 2030년에는 5억 7,860만 달러에 이를 것으로 예상됩니다. 글로벌 조직 처리 시스템 시장의 성장은 고령화 인구 증가, 생활습관병 증가, 기술 발전, 그리고 접근성 높고 질 높은 의료 서비스를 제공하기 위한 정부 정책 강화 등 다양한 요인에 의해 주도되고 있습니다.
조직 처리는 고정된 동물 또는 인체 조직을 마이크로톰으로 옮겨 조직학적 왁스 이식 및 절편 제작을 하는 과정을 포함합니다. 세포에서 수분을 제거하고 얇은 절편을 만들기 위해 냉동 배지를 주입하는 과정도 포함됩니다. 적절한 처리 후, 조직은 탈수, 세척 및 침투 과정을 거칩니다.
조직학 실험실에서의 조직 처리는 질병 진단을 위해 신체 조직을 준비하고 병리학자가 현미경으로 관찰할 수 있는 현미경 슬라이드를 제작하는 것을 포함하며, 생검, 수술 검체, 부검 조직 등이 이러한 기술에 해당합니다. 조직병리기술자는 조직 처리 및 유리 현미경 슬라이드를 다룹니다.
시장 동향
암 발병률 증가
암 발병률 증가는 예측 기간 동안 시장 성장을 촉진하는 주요 요인 중 하나입니다. 조직 처리 시스템은 암 진단 연구실에서 널리 사용됩니다. 생검 샘플은 암 진단을 위해 조직 처리기에서 처리됩니다. 이러한 시스템은 많은 수의 샘플을 처리하고, 신속하게 처리하며, 고품질 결과를 도출할 수 있습니다.

이러한 시스템은 병리학적 검사, 진단 및 연구를 위한 조직 샘플 준비 및 처리에 중요한 역할을 합니다. 정확하고 효율적인 암 진단 및 치료에 대한 수요가 증가함에 따라 조직 처리 시스템은 연구실 및 의료 시설에 필수적인 도구가 되고 있습니다.
예를 들어, 미국 암 협회(American Cancer Society) 데이터에 따르면 2023년 미국에서는 1,958,310건의 새로운 암 환자가 발생하고 약 609,820명이 암으로 사망할 것으로 예상되며, 이는 하루 평균 약 1,670명에 해당합니다. 암은 미국에서 심장 질환 다음으로 두 번째로 흔한 사망 원인입니다.
기술 발전의 증가
최근 몇 년 동안 조직 처리 절차가 상당히 개선되었습니다. 조직 처리 자동화는 유체 순환 개선, 시간 절약, 온도 제어 등 여러 가지 이점을 제공합니다. 자동화된 조직 처리기의 다른 장점으로는 조직 처리 효율 향상, 자동 세척 주기, 시약 관리 시스템 등이 있습니다. 또한 인적 오류를 줄이는 데에도 도움이 됩니다. 이러한 장점으로 인해 기술적으로 정교한 조직 처리기에 대한 수용도가 높아지고 있으며, 결과적으로 조직 처리 장비에 대한 수요가 증가하고 있습니다.
숙련된 전문가 부족
조직 처리 시스템 시장에서 숙련된 전문가가 부족한 이유는 전문 기술, 교육 프로그램, 의료 연구, 진단 및 생명 공학 분야 전문가에 대한 수요 증가와 같은 요인 때문입니다. 조직 처리기, 마이크로톰, 염색기 등의 장비가 복잡한 특성 또한 숙련된 전문가의 부족을 야기합니다.

이 문제를 해결하기 위해서는 학계, 산업계, 전문 기관 간의 협력이 필요하며, 여기에는 전문 교육, 전문성 개발 투자, 대중 인식 제고, 연구 협력, 견습 및 인턴십 프로그램 등이 포함됩니다.
이 보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
글로벌 조직 처리 시스템 시장은 제품 유형, 방식, 기술, 최종 사용자 및 지역별로 세분화됩니다.
제품 부문 중 소형 조직 처리기가 조직 처리 시스템 시장 점유율의 약 42.1%를 차지했습니다.
제품 부문 중 소형 조직 처리기는 약 42.1%의 점유율로 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 이러한 장비는 소규모 실험실에 적합하고 공간 절약 효과도 있어 시장 수요와 성장을 뒷받침하는 요인입니다. 예를 들어, Leica TP1020 반밀폐형 회전식 처리기는 신뢰성과 경제성을 고려하여 설계되었습니다. HistoCore PEARL 조직 처리기는 작은 설치 공간으로 실험실 공간을 최적화할 수 있습니다. 이 제품은 소량 처리(하루 200개 블록 이하)에 적합한 반밀폐형 탁상형 조직 처리기입니다.
지리적 시장 점유율
북미는 2022년 시장 점유율의 약 37.9%를 차지했습니다.
북미는 새로운 조직 처리기 출시, 기술 발전, 주요 업체들의 사업 확장, 고령 인구 증가, 혁신적인 의료 기술 도입, 암 발병률 증가, 그리고 이 지역의 암 검진에 대한 인식 제고 등으로 인해 예측 기간 동안 전체 시장 점유율의 약 37.9%를 차지할 것으로 예상됩니다.
예를 들어, 2022년 2월 3일, 라이카 바이오시스템즈는 HistoCore PEGASUS를 출시하며 북미 지역에서 듀얼 레토르트 조직 처리기 포트폴리오를 확장했습니다. 조직 처리의 주요 문제점은 생검 샘플과 대량의 일반 검체를 동시에 처리할 때 과소 또는 과다 처리가 발생할 수 있다는 것입니다. 이상적인 시나리오에서는 생검 샘플과 대량 샘플 조직을 특정 프로토콜을 사용하여 별도로 처리해야 합니다.

경쟁 환경
조직 처리 시스템 시장의 주요 글로벌 업체로는 JOKOH, Danaher(Leica Biosystems Nussloch GmbH), Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek 등이 있습니다.
COVID-19 영향 분석
COVID-19 팬데믹은 조직학 장비 산업에 상당한 영향을 미쳐 슬라이드 염색 및 조직 처리 시스템에 대한 수요를 감소시켰습니다. 임상 검사 제공업체는 조직 샘플 운송, 현미경 접근성, IT 시스템 확보 등과 같은 물류 문제에 직면해 있습니다. 그러나 Roche Digital Pathology와 같은 기업은 이러한 문제를 극복하기 위한 결정적인 조치를 취하여 만성 질환 진단을 위한 포괄적인 솔루션을 제공하고 있습니다. 이는 전 세계 조직 처리 시스템 시장에 상당한 영향을 미칠 것으로 예상됩니다.
러시아-우크라이나 분쟁 분석
러시아-우크라이나 전쟁은 공급망 차질과 원자재 가격 상승을 초래하여 조직 처리 시스템 시장에 큰 영향을 미쳤습니다. 여러 국가의 제재로 공급이 감소하고 인플레이션 상승은 제조업체에 새로운 어려움을 야기하고 있습니다.

제품 유형별
• 소량 조직 처리기
• 중용량 조직 처리기
• 대용량 조직 처리기
방식별
• 탁상형 조직 처리 장치
• 휴대용 조직 처리 장치
기술별
• 마이크로파 조직 처리기
• 진공 조직 처리기
최종 사용자별
• 병원
• 학술 및 연구 기관
• 진단 실험실
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
 2023년 3월, 중개 연구 개발 서비스 분야의 선도 기업인 Virscio는 전임상 약물 개발 프로그램을 강화하기 위해 새로운 병리학 및 조직 약물동태학 사업부를 설립했습니다. 제니퍼 칸 박사와 리처드 부파드가 이끄는 이 부서는 조직 처리, 슬라이드 제작, 염색, 면역조직화학, 디지털 슬라이드 스캐닝, 정량적 이미지 분석 및 병리 해석을 포함한 포괄적인 비GLP, GLP 및 GCLP 조직학 및 병리학 서비스를 제공합니다.
 2022년 9월, 조직병리학 회사인 사쿠라 피네텍 유럽(Sakura Finetek Europe)은 최신 솔루션인 고급 염색 시스템 티슈텍 지니(Tissue-Tek Genie)를 출시한다고 발표했습니다.
 2020년 9월, 사쿠라 피네텍 미국(Sakura Finetek USA, Inc.)은 티슈텍 오토텍 a120 자동 포매 시스템에서 사용할 수 있는 티슈텍 파라폼 절편 카세트 시스템(Tissue-Tek Paraform Sectionable Cassette System)의 활용 범위를 넓히는 두 가지 새로운 레이저 프린팅 가능 조직 카세트를 출시한다고 발표했습니다.

보고서 구매 이유:

• 제품 유형, 방식, 기술, 최종 사용자 및 지역별 글로벌 조직 처리 시스템 시장 세분화를 시각화하고 주요 상업 자산 및 업체들을 파악하기 위함입니다.

• 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 세그먼트를 포함한 조직 처리 시스템 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 조직 처리 시스템 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
Global Tissue Processing Systems Market reached US$ 383.2 million in 2022 and is expected to reach US$ 578.6 million by 2030 growing with a CAGR of 5.4% during the forecast period 2023-2030. The global tissue processing systems market is driven by various factors like an increase in the ageing population, an rise in lifestyle diseases, technological advancements, and rising government initiatives to provide accessible and high-quality healthcare options.
Tissue processing involves transferring fixed animal or human tissue to a microtome for histological wax implantation and section cutting. It involves removing water from cells and replacing it with frozen media for thin slices. After proper repair, the tissue undergoes dehydration, cleansing and infiltration.
Tissue processing in the histology laboratory involves preparing body tissues for disease diagnosis and producing microscopic slides for pathologists to view under a microscope and techniques include biopsies, surgical specimens, and autopsy tissues. Histotechnologists handle tissue processing and glass microscopic slides.
Market Dynamics
Rise in the Prevalence of Cancer Diseases
The rise in the prevalence of cancer is one of the key factors that helps the market to grow during the forecast period. Tissue processing systems are widely used in cancer diagnostic laboratories. Biopsy samples are processed in tissue processors for cancer diagnosis. They can manage a large number of samples, quickly process the samples, and produce high-quality results.
These systems play a crucial role in preparing and processing tissue samples for pathological examination, diagnosis, and research. As the need for accurate and efficient cancer diagnosis and treatment grows, tissue processor systems become essential tools for laboratories and healthcare facilities.
For instance, according to American Cancer Society data, in 2023 there are projected to be 1,958,310 new cancer cases and approximately 609,820 deaths from cancer are expected in the US in 2023 which is about 1,670 deaths per day. Cancer is the second most common cause of death in the US, exceeded only by heart disease.
Rise in Technological Advancements
Tissue processing procedures have been considerably improved in recent years. Tissue processor automation has several advantages, including improved fluid circulation, time savings, and temperature control. Other advantages of automated tissue processors include greatly enhanced tissue processing, automatic cleaning cycles, and reagent management systems. Furthermore, it aids in the reduction of human mistakes. This raises the acceptability of technologically sophisticated tissue processors, hence increasing demand for tissue processing equipment.
Lack of Trained Professionals
The shortage of trained professionals in the tissue processing systems market is due to factors like specialized skill sets, educational programs, and the growing demand for experts in medical research, diagnostics, and biotechnology. The intricate nature of equipment, such as tissue processors, microtomes, and staining machines, further limits the pool of skilled practitioners.
To address this issue, collaboration between academia, industry, and professional organizations is needed, including specialized education, investment in professional development, public awareness, research collaborations, and apprenticeship and internship initiatives.
For more details on this report - Request for Sample
Segment Analysis
The global tissue processing systems market is segmented based on product type, modality, technology, end user and region.
The Small Volume Tissue Processors From The Product Segment Accounted for Approximately 42.1 % of the Tissue Processing Systems Market Share
The small volume of tissue processors from the product segment with around 42.1% is expected to dominate during the forecast period. These are suitable for small laboratory sizes as well as also save space the factors supporting its demand and growth in the market. For instance, the Leica TP1020 semi-enclosed rotary processor is designed for reliability and economy. It can optimize laboratory space with the small footprint of the HistoCore PEARL tissue processor. It is a semi-enclosed benchtop tissue processor with small volumes (≤200 blocks/day).
Geographical Penetration
North America Accounted for Approximately 37.9% of the Market Share in 2022
North America is estimated to hold about 37.9% of the total market share throughout the forecast period, due to the launches of new tissue processors, technological advancements, expansion by key players, growing geriatric population along with adoption of innovative medical technology, rise in cancer incidence, and raising awareness about cancer screening in this region.
For instance, on 3rd February 2022, Leica Biosystems expanded its Dual-Retort Tissue Processor portfolio in North America with HistoCore PEGASUS. The main issue with tissue processing is processing biopsy and large routine specimens in the same run, causing under- or over-processing. In ideal scenarios, biopsy and larger sample tissues should be processed separately using a specific protocol.
Competitive Landscape
The major global players in the tissue processing systems market include JOKOH, Danaher(Leica Biosystems Nussloch GmbH), Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek and among others.
COVID-19 Impact Analysis
The COVID-19 pandemic has significantly impacted the histology equipment industry, limiting demand for slide staining and tissue processing systems. Clinical testing providers face logistical challenges such as transportation of tissue samples, access to microscopes, and IT systems. However, companies like Roche Digital Pathology have made decisive steps to overcome these challenges, offering a comprehensive solution for chronic illness diagnosis. This will likely significantly influence the worldwide tissue processing systems market.
Russia Ukraine Conflict Analysis
The Russia-Ukraine war significantly impacted the tissue processing systems market, causing supply chain disruptions and increased raw material costs. Sanctions from several countries cut supply while rising inflation presents new challenges for manufacturers.
By Product Type
• Small-volume tissue processors
• Medium Volume tissue processors
• High Volume tissue processors
By Modality
• Bench Top tissue processing unit
• Portable tissue processing unit
By Technology
• Microwave tissue processors
• Vaccum tissue processors
By End User
• Hospitals
• Academic and Research Institutes
• Diagnostic Laboratories
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
 In March 2023, Virscio, a leading provider of translational research and development services, launched a new Pathology and Tissue Pharmacodynamics Division to enhance preclinical drug development programs. The division, led by Dr Jennifer Cann and Richard Bouffard, offers comprehensive non-GLP, GLP, and GCLP histology and pathology services, including tissue processing, slide preparation, staining, immunohistochemistry, digital slide scanning, quantitative image analysis, and pathology interpretation.
 In September 2022, the histopathology company Sakura Finetek Europe announced the launch of its newest solution Tissue-Tek Genie, an advanced staining system, entering the market.
 In September 2020, Sakura Finetek USA, Inc. announced the launch of two new laser-printable tissue cassettes, broadening the Tissue-Tek Paraform Sectionable Cassette System for use on the Tissue-Tek AutoTEC a120 Automated Embedding Systems.
Why Purchase the Report?
• To visualize the global tissue processing systems market segmentation based on product type, modality, technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of tissue processing systems market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global tissue processing systems market report would provide approximately 53 tables, 54 figures and 195 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Modality
3.3. Snippet by Technology
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the Prevalence of Cancer Diseases
4.1.1.2. Rise in Technological Advancements
4.1.2. Restraints
4.1.2.1. Lack of Trained Professionals
4.1.3. Opportunity
4.1.3.1. Rise in Focus on Personalized Medicine
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Small Volume Tissue Processors *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Medium Volume Tissue Processors
7.4. High Volume Tissue Processors
8. By Modality
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. Bench Top Tissue Processing Unit*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Portable Tissue Processing Unit
9. By Technology
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.1.2. Market Attractiveness Index, By Technology
9.2. Microwave Tissue Processors *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Vaccum Tissue Processors
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Academic and Research Institutes
10.4. Diagnostic Laboratories
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
Australia
11.5.7.4. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Danaher(Leica Biosystems Nussloch GmbH)*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. JOKOH
13.3. Medite Medical GmbH
13.4. Milestone SRL
13.5. Sakura Finetek USA, Inc.
13.6. SLEE medical GmbH
13.7. Bio Optica
13.8. Histo-Line Laboratories
13.9. General Data Company Inc
13.10. Unimeditrek
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Danaher(Leica Biosystems Nussloch GmbH), 4.	Key Developments, JOKOH, Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek

표 목록 (Tables)

List of Tables

Table 1 Global Tissue Processing Systems Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 2 Global Tissue Processing Systems Market Value, By Modality, 2022, 2026 & 2030 (US$ Million)

Table 3 Global Tissue Processing Systems Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 4 Global Tissue Processing Systems Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 5 Global Tissue Processing Systems Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 6 Global Tissue Processing Systems Market Value, By Product, 2022, 2026 & 2030 (US$ Million)

Table 7 Global Tissue Processing Systems Market Value, By Product, 2021-2030 (US$ Million)

Table 8 Global Tissue Processing Systems Market Value, By Modality, 2022, 2026 & 2030 (US$ Million)

Table 9 Global Tissue Processing Systems Market Value, By Modality, 2021-2030 (US$ Million)

Table 10 Global Tissue Processing Systems Market Value, By Technology, 2022, 2026 & 2030 (US$ Million)

Table 11 Global Tissue Processing Systems Market Value, By Technology, 2021-2030 (US$ Million)

Table 12 Global Tissue Processing Systems Market Value, By End User, 2022, 2026 & 2030 (US$ Million)

Table 13 Global Tissue Processing Systems Market Value, By End User, 2021-2030 (US$ Million)

Table 14 Global Tissue Processing Systems Market Value, By Region, 2022, 2026 & 2030 (US$ Million)

Table 15 Global Tissue Processing Systems Market Value, By Region, 2021-2030 (US$ Million)

Table 16 North America Tissue Processing Systems Market Value, By Product, 2021-2030 (US$ Million)

Table 17 North America Tissue Processing Systems Market Value, By Modality, 2021-2030 (US$ Million)

Table 18 North America Tissue Processing Systems Market Value, By Technology, 2021-2030 (US$ Million)

Table 19 North America Tissue Processing Systems Market Value, By End User, 2021-2030 (US$ Million)

Table 20 North America Tissue Processing Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 21 South America Tissue Processing Systems Market Value, By Product, 2021-2030 (US$ Million)

Table 22 South America Tissue Processing Systems Market Value, By Modality, 2021-2030 (US$ Million)

Table 23 South America Tissue Processing Systems Market Value, By Technology, 2021-2030 (US$ Million)

Table 24 South America Tissue Processing Systems Market Value, By End User, 2021-2030 (US$ Million)

Table 25 South America Tissue Processing Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 26 Europe Tissue Processing Systems Market Value, By Product, 2021-2030 (US$ Million)

Table 27 Europe Tissue Processing Systems Market Value, By Modality, 2021-2030 (US$ Million)

Table 28 Europe Tissue Processing Systems Market Value, By Technology, 2021-2030 (US$ Million)

Table 29 Europe Tissue Processing Systems Market Value, By End User, 2021-2030 (US$ Million)

Table 30 Europe Tissue Processing Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 31 Asia-Pacific Tissue Processing Systems Market Value, By Product, 2021-2030 (US$ Million)

Table 32 Asia-Pacific Tissue Processing Systems Market Value, By Modality, 2021-2030 (US$ Million)

Table 33 Asia-Pacific Tissue Processing Systems Market Value, By Technology, 2021-2030 (US$ Million)

Table 34 Asia-Pacific Tissue Processing Systems Market Value, By End User, 2021-2030 (US$ Million)

Table 35 Asia-Pacific Tissue Processing Systems Market Value, By Country, 2021-2030 (US$ Million)

Table 36 Middle East & Africa Tissue Processing Systems Market Value, By Product, 2021-2030 (US$ Million)

Table 37 Middle East & Africa Tissue Processing Systems Market Value, By Modality, 2021-2030 (US$ Million)

Table 38 Middle East & Africa Tissue Processing Systems Market Value, By Technology, 2021-2030 (US$ Million)

Table 39 Middle East & Africa Tissue Processing Systems Market Value, By End User, 2021-2030 (US$ Million)

Table 40 Danaher(Leica Biosystems Nussloch GmbH): Overview

Table 41 Danaher(Leica Biosystems Nussloch GmbH): Product Portfolio

Table 42 Danaher(Leica Biosystems Nussloch GmbH): Key Developments

Table 43 JOKOH: Overview

Table 44 JOKOH: Product Portfolio

Table 45 JOKOH: Key Developments

Table 46 Medite Medical GmbH: Overview

Table 47 Medite Medical GmbH: Product Portfolio

Table 48 Medite Medical GmbH: Key Developments

Table 49 Milestone SRL: Overview

Table 50 Milestone SRL: Product Portfolio

Table 51 Milestone SRL: Key Developments

Table 52 Sakura Finetek USA, Inc.: Overview

Table 53 Sakura Finetek USA, Inc.: Product Portfolio

Table 54 Sakura Finetek USA, Inc.: Key Developments

Table 55 SLEE medical GmbH: Overview

Table 56 SLEE medical GmbH: Product Portfolio

Table 57 SLEE medical GmbH: Key Developments

Table 58 Bio Optica: Overview

Table 59 Bio Optica: Product Portfolio

Table 60 Bio Optica: Key Developments

Table 61 Histo-Line Laboratories: Overview

Table 62 Histo-Line Laboratories: Product Portfolio

Table 63 Histo-Line Laboratories: Key Developments

Table 64 General Data Company Inc: Overview

Table 65 General Data Company Inc: Product Portfolio

Table 66 General Data Company Inc: Key Developments

Table 67 Unimeditrek: Overview

Table 68 Unimeditrek: Product Portfolio

Table 69 Unimeditrek: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 2 Global Tissue Processing Systems Market Share, By Product, 2022 & 2030 (%)

Figure 3 Global Tissue Processing Systems Market Share, By Modality, 2022 & 2030 (%)

Figure 4 Global Tissue Processing Systems Market Share, By Technology, 2022 & 2030 (%)

Figure 5 Global Tissue Processing Systems Market Share, By End User, 2022 & 2030 (%)

Figure 6 Global Tissue Processing Systems Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Tissue Processing Systems Market Y-o-Y Growth, By Product, 2022-2030 (%)

Figure 8 Small Volume Tissue Processors Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 9 Medium Volume Tissue Processors Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 10 High Volume Tissue Processors Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 11 Global Tissue Processing Systems Market Y-o-Y Growth, By Modality, 2022-2030 (%)

Figure 12 Bench Top Tissue Processing Unit Modality in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 13 Portable Tissue Processing Unit Modality in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 14 Global Tissue Processing Systems Market Y-o-Y Growth, By Technology, 2022-2030 (%)

Figure 15 Microwave Tissue Processors Technology in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 16 Vaccum Tissue Processors Technology in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 17 Global Tissue Processing Systems Market Y-o-Y Growth, By End User, 2022-2030 (%)

Figure 18 Hospitals End User in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 20 Academic and Research Institutes End User in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 21 Diagnostic Laboratories End User in Global Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 22 Global Tissue Processing Systems Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 23 North America Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 24 Asia-Pacific Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 25 Europe Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 26 South America Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 27 Middle East and Africa Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 28 North America Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 29 North America Tissue Processing Systems Market Share, By Product, 2022 & 2030 (%)

Figure 30 North America Tissue Processing Systems Market Share, By Modality, 2022 & 2030 (%)

Figure 31 North America Tissue Processing Systems Market Share, By Technology, 2022 & 2030 (%)

Figure 32 North America Tissue Processing Systems Market Share, By End User, 2022 & 2030 (%)

Figure 33 North America Tissue Processing Systems Market Share, By Country, 2022 & 2030 (%)

Figure 34 South America Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 35 South America Tissue Processing Systems Market Share, By Product, 2022 & 2030 (%)

Figure 36 South America Tissue Processing Systems Market Share, By Modality, 2022 & 2030 (%)

Figure 37 South America Tissue Processing Systems Market Share, By Technology, 2022 & 2030 (%)

Figure 38 South America Tissue Processing Systems Market Share, By End User, 2022 & 2030 (%)

Figure 39 South America Tissue Processing Systems Market Share, By Country, 2022 & 2030 (%)

Figure 40 Europe Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 41 Europe Tissue Processing Systems Market Share, By Product, 2022 & 2030 (%)

Figure 42 Europe Tissue Processing Systems Market Share, By Modality, 2022 & 2030 (%)

Figure 43 Europe Tissue Processing Systems Market Share, By Technology, 2022 & 2030 (%)

Figure 44 Europe Tissue Processing Systems Market Share, By End User, 2022 & 2030 (%)

Figure 45 Europe Tissue Processing Systems Market Share, By Country, 2022 & 2030 (%)

Figure 46 Asia-Pacific Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 47 Asia-Pacific Tissue Processing Systems Market Share, By Product, 2022 & 2030 (%)

Figure 48 Asia-Pacific Tissue Processing Systems Market Share, By Modality, 2022 & 2030 (%)

Figure 49 Asia-Pacific Tissue Processing Systems Market Share, By Technology, 2022 & 2030 (%)

Figure 50 Asia-Pacific Tissue Processing Systems Market Share, By End User, 2022 & 2030 (%)

Figure 51 Asia-Pacific Tissue Processing Systems Market Share, By Country, 2022 & 2030 (%)

Figure 52 Middle East & Africa Tissue Processing Systems Market Value, 2021-2030 (US$ Million)

Figure 53 Middle East & Africa Tissue Processing Systems Market Share, By Product, 2022 & 2030 (%)

Figure 54 Middle East & Africa Tissue Processing Systems Market Share, By Modality, 2022 & 2030 (%)

Figure 55 Middle East & Africa Tissue Processing Systems Market Share, By Technology, 2022 & 2030 (%)

Figure 56 Middle East & Africa Tissue Processing Systems Market Share, By End User, 2022 & 2030 (%)

Figure 57 Danaher(Leica Biosystems Nussloch GmbH): Financials

Figure 58 JOKOH: Financials

Figure 59 Medite Medical GmbH: Financials

Figure 60 Milestone SRL: Financials

Figure 61 Sakura Finetek USA, Inc.: Financials

Figure 62 SLEE medical GmbH: Financials

Figure 63 Bio Optica: Financials

Figure 64 Histo-Line Laboratories: Financials

Figure 65 General Data Company Inc: Financials

Figure 66 Unimeditrek: Financials

글로벌 조직 처리 시스템 시장 – 2023-2030

Global Tissue Processing Systems Market - 2023-2030